Allovectin velimogene aliplasmid: Additional Phase III data

Additional data from the single-blind, international Phase III AIMM trial in 390 chemotherapy-naïve patients with recurrent stage III or IV

Read the full 209 word article

How to gain access

Continue reading with a
two-week free trial.